| Literature DB >> 26645353 |
Katsura Kakoki1, Yasuyoshi Miyata2, Youhei Shida3, Tomoaki Hakariya4, Kosuke Takehara5, Seiya Izumida6, Motohiro Sekino7, Naoe Kinoshita8, Tsukasa Igawa9,10, Junya Fukuoka11, Hideki Sakai12.
Abstract
BACKGROUND: Pheochromocytoma is a neuroendocrine tumor that predominantly presents with hypertension, palpitations, and tachycardia due to excessive catecholamine excretion. Although pheochromocytoma multisystem crisis (PMC) is relatively rare, urologists and clinicians should focus on early diagnosis as delay in initiating the appropriate treatment can lead to mortality CASEEntities:
Mesh:
Year: 2015 PMID: 26645353 PMCID: PMC4673852 DOI: 10.1186/s13104-015-1738-z
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Abdominal computed tomography revealed a large left adrenal mass with heterogeneous enhancement and extended intensity compatible with ileus
Fig. 2Resected specimen showing a tumor measuring 14 cm in diameter. There was hemorrhage and necrosis within the tumor
Fig. 3Hematoxylin-eosin staining (magnification: ×40)
Fig. 4Ki-67 staining. The distribution of Ki-67-stained cells was nonspecific (magnification: ×200)
Characteristics, physical conditions, treatments, and outcomes of patients with pheochromocytoma multisystem crisis
| Sex | Age (years) | S/DBP (mmHg) | BT (°C) | Size (cm) | Ad | NAd | Dopa | Operation (days)b | Outcome | Year [Ref] |
|---|---|---|---|---|---|---|---|---|---|---|
| (Times of upper limit) | ||||||||||
| F | 53 | 210/110 | 40 | 6.3 | 101.1 | 103.5 | – | Not performed | Died | 1988 [ |
| F | 62 | 285/140 | 40.5 | 10 | 96.0 | 14.8 | – | Emergency | Survived | 1988 [ |
| F | 50 | 200/90 | 40 | 7 | 43.3 | 23.4 | – | 7 | Survived | 1988 [ |
| F | 65 | 120/80 | 39.5 | 4 | – | – | – | >21 | Survived | 1993 [ |
| M | 31 | 164/40 | 41.0 | – | 10a | 6.7a | 1.3a | 36 | Survived | 1997 [ |
| F | 50 | 160/100 | 41.5 | – | – | – | – | Not performed | Died | 2002 [ |
| F | 41 | 190/130 | 41.0 | – | – | – | – | – | Survived | 2006 [ |
| F | 26 | 160/110 | – | 4.5 | – | – | – | Not performed | Died | 2008 [ |
| M | 39 | 240/140 | – | 5.5 | 41.0 | 49.6 | – | Emergency | Survived | 2008 [ |
| F | 52 | 300/200 | 39.9 | 10 | – | – | – | Not performed | Died | 2010 [ |
| F | 52 | 162/104 | 35.8 | – | 103.5 | 53.9 | 53.1 | – | Survived | 2010 [ |
| M | 27 | 160/120 | – | 5 | – | – | – | Not performed | Died | 2012 [ |
| M | 70 | 210/146 | 40.1 | 5 | 1047.5 | 61.5 | 103.5 | 5 | Survived | Present |
M male, F female, S/DBP systolic/diastolic blood pressure, BT body temperature, Ad adrenalin, NAd noradrenalin, Dopa dopamine, Ref reference number
a24 h urine correction
bOperation day following admission
Mean proliferation indexes of benign and malignant adrenal pheochromocytoma
| Benign | |||||||||
| N | 23b | 16 | 93 | 21 | 20 | – | 41 | 44 | 14 |
| PI (%) | 1 | 0.75 | 0.21 | 0.9 | <1 | – | 0.8 | <1 | 2.2 |
| Malignant | |||||||||
| N | 10 | 15 | 36 | 4 | 3c | 43 | 5 | 11 | 7 |
| PI (%) | 5 | 13.9 | 3.0 | 4.3 | <1 | 7.8 | 1.4 | – | 14.1 |
| Cut-offa | >3 | ≥3 | >2.5 | – | – | >5 | >2 | >5 | – |
| Year | 1998 | 2000 | 2000 | 2001 | 2003 | 2004 | 2008 | 2010 | 2012 |
| Reference | [ | [ | [ | [ | [ | [ | [ | [ | [ |
PI proliferation index
aCut-off of PI (%) between benign and malignant pheochromocytoma
bIncluding extra-adrenal tumors
cPatients without metastasis at diagnosis